Literature DB >> 15133039

Identification of an androgen response element in intron 8 of the sterol regulatory element-binding protein cleavage-activating protein gene allowing direct regulation by the androgen receptor.

Hannelore Heemers1, Guy Verrijdt, Sophie Organe, Frank Claessens, Walter Heyns, Guido Verhoeven, Johannes V Swinnen.   

Abstract

Sterol regulatory element-binding proteins (SREBPs) are transcription regulators that play a pivotal role in intracellular lipid homeostasis. They are synthesized as inactive precursor proteins in the endoplasmic reticulum, where they are retained by SREBP cleavage-activating protein (SCAP), a sterol sensing protein that in turn is linked to a retention protein complex. Low intracellular sterol concentrations weaken the interaction of SCAP with its retention proteins and allow translocation of the SREBP.SCAP complex to the Golgi compartment where SREBP is proteolytically cleaved and activated. Previous studies on the mechanisms by which androgens provoke a coordinated activation of lipogenic pathways in prostate cancer cells have suggested an alternative pathway of activation in which androgens increase the expression of SCAP and favor translocation of the SREBP.SCAP complex to the Golgi apparatus by disturbing the balance between SCAP and its retention proteins. Here we show that the SCAP gene contains an androgen-responsive region located in intron 8. This region interacts directly with the androgen receptor and confers androgen responsiveness to promoter-reporter constructs transfected in LNCaP cells. It contains a noncanonical androgen response element GGAAGAaaaTGTACC that interacts not only with the androgen receptor but also with the glucocorticoid receptor and that also confers glucocorticoid responsiveness. The identification of a steroid response element in intron 8 of the SCAP gene further supports the contention that SCAP is a direct target for steroid hormone action.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133039     DOI: 10.1074/jbc.M401615200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Effect of Daxx on cholesterol accumulation in hepatic cells.

Authors:  Qin-Hui Tuo; Lei Liang; Bing-Yang Zhu; Xuan Cao; Duan-Fang Liao
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

2.  Androgen modulation of coregulator expression in prostate cancer cells.

Authors:  Hannelore V Heemers; Kevin M Regan; Lucy J Schmidt; S Keith Anderson; Karla V Ballman; Donald J Tindall
Journal:  Mol Endocrinol       Date:  2009-01-22

3.  Estrogen receptor alpha regulates expression of the breast cancer 1 associated ring domain 1 (BARD1) gene through intronic DNA sequence.

Authors:  Amy L Creekmore; Yvonne S Ziegler; Jamie L Bonéy; Ann M Nardulli
Journal:  Mol Cell Endocrinol       Date:  2007-01-16       Impact factor: 4.102

4.  Expression of Tubb3, a beta-tubulin isotype, is regulated by androgens in mouse and rat Sertoli cells.

Authors:  Karel De Gendt; Evi Denolet; Ariane Willems; Veerle W Daniels; Liesbeth Clinckemalie; Sarah Denayer; Miles F Wilkinson; Frank Claessens; Johannes V Swinnen; Guido Verhoeven
Journal:  Biol Reprod       Date:  2011-07-06       Impact factor: 4.285

5.  Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells.

Authors:  Lori Rice; Renita Handayani; Yuehua Cui; Theresa Medrano; Von Samedi; Henry Baker; Nancy J Szabo; Charles J Rosser; Steve Goodison; Kathleen T Shiverick
Journal:  J Nutr       Date:  2007-04       Impact factor: 4.798

6.  An essential requirement for the SCAP/SREBP signaling axis to protect cancer cells from lipotoxicity.

Authors:  Kevin J Williams; Joseph P Argus; Yue Zhu; Moses Q Wilks; Beth N Marbois; Autumn G York; Yoko Kidani; Alexandra L Pourzia; David Akhavan; Dominique N Lisiero; Evangelia Komisopoulou; Amy H Henkin; Horacio Soto; Brian T Chamberlain; Laurent Vergnes; Michael E Jung; Jorge Z Torres; Linda M Liau; Heather R Christofk; Robert M Prins; Paul S Mischel; Karen Reue; Thomas G Graeber; Steven J Bensinger
Journal:  Cancer Res       Date:  2013-02-25       Impact factor: 12.701

7.  Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance.

Authors:  Scott M Dehm; Lucy J Schmidt; Hannelore V Heemers; Robert L Vessella; Donald J Tindall
Journal:  Cancer Res       Date:  2008-07-01       Impact factor: 12.701

8.  An androgen-independent mechanism underlying the androgenic effects of 3-methylcholanthrene, a potent aryl hydrocarbon receptor agonist.

Authors:  Noriko Sanada; Yuka Gotoh-Kinoshita; Naoya Yamashita; Ryoichi Kizu
Journal:  Toxicol Res (Camb)       Date:  2020-05-14       Impact factor: 3.524

9.  Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.

Authors:  Divya Patel; Swathi Chinaranagari; Jaideep Chaudhary
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

10.  Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcification.

Authors:  Bo-Kyung Son; Masahiro Akishita; Katsuya Iijima; Sumito Ogawa; Koji Maemura; Jing Yu; Kenichi Takeyama; Shigeaki Kato; Masato Eto; Yasuyoshi Ouchi
Journal:  J Biol Chem       Date:  2010-01-04       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.